Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
Operating Income
Valeo Pharma Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Valeo Pharma Inc
TSX:VPH
|
Operating Income
-CA$17.2m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
Bausch Health Companies Inc
TSX:BHC
|
Operating Income
$1.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
26%
|
CAGR 10-Years
6%
|
|
Theratechnologies Inc
TSX:TH
|
Operating Income
-$7.5m
|
CAGR 3-Years
27%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
2%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Operating Income
CA$6.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Spectral Medical Inc
TSX:EDT
|
Operating Income
-CA$11.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
0%
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Operating Income
$10m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-5%
|
See Also
What is Valeo Pharma Inc's Operating Income?
Operating Income
-17.2m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Operating Income amounts to -17.2m CAD.
What is Valeo Pharma Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-48%
Over the last year, the Operating Income growth was 10%. The average annual Operating Income growth rates for Valeo Pharma Inc have been -59% over the past three years , -48% over the past five years .